| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 14 |
| 1 | ALENDRONATE SODIUM | 5 |
| 2 | RISEDRONATE SODIUM | 3 |
| 3 | CALCIUM | 2 |
| 4 | CONJUGATED ESTROGENS | 2 |
| 5 | ESOMEPRAZOLE MAGNESIUM | 2 |
| 6 | ESTROGENS, CONJUGATED | 2 |
| 7 | ADALIMUMAB | 1 |
| 8 | ADALIMUMAB-AATY | 1 |
| 9 | ADALIMUMAB-ADAZ | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CONJUGATED ESTROGENS/BAZEDOXIFENE | 1 | 0.0011 |
| 1 | TEPROTUMUMAB | 1 | 0.0002 |
| 2 | BUROSUMAB | 1 | 0.0002 |
| 3 | RISEDRONATE SODIUM | 3 | 0.0001 |
| 4 | DENOSUMAB | 14 | 0.0001 |
| 5 | INDAPAMIDE | 1 | 0.0001 |
| 6 | ALENDRONATE SODIUM | 5 | 0.0000 |
| 7 | TESTOSTERONE | 1 | 0.0000 |
| 8 | IMATINIB MESYLATE | 1 | 0.0000 |
| 9 | CONJUGATED ESTROGENS | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 1 | RANK Ligand Inhibitor [EPC] | 14 | 0.0001 |
| 2 | Androgen [EPC] | 1 | 0.0000 |
| 3 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 5 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 6 | Estrogen [EPC] | 3 | 0.0000 |
| 7 | Calcium [EPC] | 2 | 0.0000 |
| 8 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 9 | Parathyroid Hormone Analog [EPC] | 1 | 0.0000 |